Convection-enhanced delivery (CED) has been introduced as a concept in cancer treatment to generate high local concentrations of anticancer therapeutics and overcome the limited diffusional distribution, e.g., in the brain. RNA interference provides interesting therapeutic options to fight cancer cells but requires nanoparticulate (NP) carriers with a size below 100 nm as well as a low zeta potential for CED application. In this study, we investigated calcium phosphate NPs (CaP-NPs) as siRNA carriers for CED application. Since CaP-NPs tend to aggregate, we introduced a new terpolymer (o14PEGMA(1:1:2.5) NH3) for stabilization of CaP-NPs intended for delivery of siRNA to brain cancer cells. This small terpolymer provides PEG chains for steric...
International audienceThe present study describes hybrid nanoparticles, built by alternate depositio...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
Despite the long history of nanoparticulate calcium phosphate (CaP) as a non-viral transfection agen...
Lipid coated calcium phosphate (LCP) nanoparticles (NPs) remain an attractive option for siRNA syste...
A lipid coated calcium phosphate (LCP) nanoparticle (NP) formulation was developed for efficient del...
Small interfering RNAs (siRNA) are short nucleic acid fragments of about 20–27 nucleotides, which ca...
In this study, hyaluronan (HA)-functionalized calcium phosphate nanoparticles (CaP-AHA/siRNA NPs) we...
Aim: To develop biocompatible and bioresorbable negatively charged calcium phosphate nanoparticles (...
Calcium phosphate (CaP) nanoparticles(NP) with an asymmetric lipid bilayer coating have been designe...
This study introduces a novel cross-linking strategy capable of successfully stabilizing CaP nanopar...
The conjugation of ligands to nanoparticle platforms for the target delivery of therapeutic agents t...
In the past few decades, the successful theranostic application of nanomaterials in drug delivery sy...
The present study describes hybrid nanoparticles, built by alternate deposition of siRNA and modifie...
© 2019 Zhe SunDespite the recent advances in cancer treatment, this disease continues to pose a seri...
Synthetic calcium phosphates (CaPs) are the most widely accepted bioceramics for the repair and reco...
International audienceThe present study describes hybrid nanoparticles, built by alternate depositio...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
Despite the long history of nanoparticulate calcium phosphate (CaP) as a non-viral transfection agen...
Lipid coated calcium phosphate (LCP) nanoparticles (NPs) remain an attractive option for siRNA syste...
A lipid coated calcium phosphate (LCP) nanoparticle (NP) formulation was developed for efficient del...
Small interfering RNAs (siRNA) are short nucleic acid fragments of about 20–27 nucleotides, which ca...
In this study, hyaluronan (HA)-functionalized calcium phosphate nanoparticles (CaP-AHA/siRNA NPs) we...
Aim: To develop biocompatible and bioresorbable negatively charged calcium phosphate nanoparticles (...
Calcium phosphate (CaP) nanoparticles(NP) with an asymmetric lipid bilayer coating have been designe...
This study introduces a novel cross-linking strategy capable of successfully stabilizing CaP nanopar...
The conjugation of ligands to nanoparticle platforms for the target delivery of therapeutic agents t...
In the past few decades, the successful theranostic application of nanomaterials in drug delivery sy...
The present study describes hybrid nanoparticles, built by alternate deposition of siRNA and modifie...
© 2019 Zhe SunDespite the recent advances in cancer treatment, this disease continues to pose a seri...
Synthetic calcium phosphates (CaPs) are the most widely accepted bioceramics for the repair and reco...
International audienceThe present study describes hybrid nanoparticles, built by alternate depositio...
Specific gene knockdown facilitated by short interfering RNA (siRNA) is a potential approach for sup...
Despite the long history of nanoparticulate calcium phosphate (CaP) as a non-viral transfection agen...